EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy

Helal F. Hetta, Yasmin N. Ramadan, Ahmad A. Alharbi, Shomokh Alsharef, Tala T. Alkindy, Alanoud Alkhamali, Abdullah S. Albalawi, Hussein El Amin

Immuno · 21.10.2024 · 4 (4) · 400-425

DOI: 10.3390/immuno4040026 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Immuno, online erschienen am 21.10.2024. Verfasst von Helal F. Hetta und 7 weiteren Autor:innen. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 225 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammatory bowel disease (IBD) is a chronic complicated inflammatory gut pathological disorder and is categorized into ulcerative colitis (UC) and Crohn’s disease (CD). Although the cause of IBD is unclear, dysbiosis of the gut microbiota is thought to be a key factor in the disease’s progression. The gut microbiome serves as a metabolic organ and promotes wellness by carrying out several biological activities. Any modification in the makeup of the gut microbiome leads to several pathological conditions, including IBD. In this review, we emphasize the key metabolic processes that control host–microbiome interaction and its impact on host health. We also discuss the association between microbiome dysbiosis (bacteriome, virome, and mycobiome) and the progression of IBD. Finally, we will highlight microbiome-based therapy as a novel and promising strategy to treat and manage IBD.

Zitieren

APA

Hetta, H. F., Ramadan, Y. N., Alharbi, A. A., Alsharef, S., Alkindy, T. T., Alkhamali, A., Albalawi, A. S., & Amin, H. E. (2024). Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy. Immuno, 4(4), 400-425. https://doi.org/10.3390/immuno4040026

Vancouver

Hetta HF, Ramadan YN, Alharbi AA, Alsharef S, Alkindy TT, Alkhamali A, et al. Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy. Immuno. 2024;4(4):400-425. doi:10.3390/immuno4040026

BibTeX
@article{Hetta2024,
  author = {Hetta, Helal F. and Ramadan, Yasmin N. and Alharbi, Ahmad A. and Alsharef, Shomokh and Alkindy, Tala T. and Alkhamali, Alanoud and Albalawi, Abdullah S. and Amin, Hussein El},
  title = {Gut Microbiome as a Target of Intervention in Inflammatory Bowel Disease Pathogenesis and Therapy},
  journal = {Immuno},
  year = {2024},
  volume = {4},
  number = {4},
  pages = {400--425},
  doi = {10.3390/immuno4040026}
}
Kostenlos starten →